Four-part digital program addressing Parkinson’s disease through dopamine support, neuroinflammation reduction, gentle detoxification, and twelve structured daily lifestyle habits, distributed via ClickBank with a 60-day satisfaction guarantee

The Parkinson’s Protocol, a four-part digital lifestyle program by Jodi Knapp covering Parkinson’s science, dopamine-boosting nutrition and movement, gentle detoxification strategies, and twelve daily habits designed to support brain health and slow symptom progression, with lifetime digital access and no recurring costs.

BOISE, Idaho, August 5, 2026 — Blue Heron Health News today announced the commercial availability of The Parkinson’s Protocol, a four-part digital lifestyle program authored by Jodi Knapp, distributed via ClickBank, and backed by a 60-day satisfaction guarantee. The program is available for direct purchase through the company’s authorized retail portal at blueheronhealthnews.com and is delivered as a digital PDF/e-book with lifetime access and unlimited downloads.

The Parkinson’s Protocol is a structured twelve-step digital lifestyle guide for adults living with Parkinson’s disease. Its four-part framework covers the science of Parkinson’s and dopamine deficiency, traditional and alternative treatment approaches, dopamine-boosting nutrition and detoxification strategies, and a set of twelve daily habits designed to minimize exposure to Parkinson’s risk factors and support ongoing brain and motor function. The program is grounded in published research on neuroinflammation, mitochondrial dysfunction, the gut-brain axis, and environmental toxin exposure as contributors to dopaminergic neuron loss. The program is available as a digital PDF and includes an optional physical book edition at cost of printing only.

The Parkinson's Protocol Reviews

Product Overview

The Parkinson’s Protocol is a digital lifestyle program authored by Jodi Knapp of Blue Heron Health News. The company states that the program was developed to provide individuals managing Parkinson’s disease with a structured, evidence-informed framework for addressing the lifestyle and environmental contributors to dopamine deficiency — including neuroinflammation, oxidative stress, mitochondrial dysfunction, gut microbiome imbalance, and environmental toxin exposure — through targeted dietary modification, gentle detoxification, physical activity, and daily habit adjustments. The program does not claim to replace medical treatment and is explicitly designed to complement conventional Parkinson’s care.

The program is authored by Jodi Knapp, a health researcher and writer associated with Blue Heron Health News. All scientific references cited in this press release describe independent research on the mechanisms addressed by the program, conducted under conditions unaffiliated with Blue Heron Health News. They do not constitute clinical evidence that this program produces equivalent outcomes to those described in the cited studies.

“The Parkinson’s Protocol was developed to give individuals living with Parkinson’s a practical, step-by-step framework grounded in the published science of neuroinflammation, dopamine production, and lifestyle-based neuroprotection. The program draws on peer-reviewed research on the gut-brain axis, mitochondrial health, and environmental toxin exposure. We do not claim the program replicates outcomes from the independent studies cited within it, which were conducted under conditions unaffiliated with our organization. Readers are encouraged to continue working closely with their healthcare provider.”

— Jodi Knapp, Author, The Parkinson’s Protocol / Blue Heron Health News

Program Content Overview

The following section describes the four parts comprising The Parkinson’s Protocol, as disclosed by the author. Each part description is accompanied by independent published research on the specific mechanism or intervention addressed. These citations describe research conducted under conditions unaffiliated with Blue Heron Health News and do not constitute clinical evidence that this program produces equivalent outcomes to those described in the cited studies.

Part 1 — Understanding Parkinson’s Disease. Part 1 provides a foundational overview of Parkinson’s disease, covering the role of dopamine in motor and reward function, the loss of substantia nigra neurons as the primary driver of motor symptom progression, and the modifiable risk and contributing factors documented in Parkinson’s research — including neuroinflammation, mitochondrial dysfunction, environmental toxin exposure, elevated BMI, chronic stress, poor diet, and physical inactivity. Research published in Nature Reviews Neuroscience (Dauer, W., & Przedborski, S., 2003, “Parkinson’s disease: mechanisms and models,” doi:10.1038/nrn1244) examined the cellular and molecular mechanisms underlying dopaminergic neuron loss in the substantia nigra, including mitochondrial dysfunction, oxidative stress, and neuroinflammatory pathways in adult subjects. The study was conducted independently and was not affiliated with Blue Heron Health News.

Part 2 — Traditional Solutions and Alternative Approaches. Part 2 covers the most common conventional Parkinson’s treatments — including levodopa/carbidopa therapy, dopamine agonists, MAO-B inhibitors, and surgical interventions — alongside their documented benefits, long-term side effect profiles, and known limitations in symptom management. The section also introduces alternative and complementary approaches that have been evaluated in peer-reviewed literature for their potential role in supporting dopaminergic function alongside conventional care. A review published in The Lancet Neurology (Bhidayasiri, R., & Tarsy, D., 2012, “Movement disorders: a video atlas,” and Connolly, B.S., & Lang, A.E., 2014, “Pharmacological treatment of Parkinson disease: a review,” doi:10.1001/jama.2014.3654) examined the pharmacological treatment landscape for Parkinson’s disease — including efficacy, limitations, and side effect profiles of primary medication classes — in adult subjects across multiple clinical study populations. The study was conducted independently and was not affiliated with Blue Heron Health News.

Part 3 — Detoxification and Dopamine Support. Part 3 covers the program’s core intervention strategies: dietary approaches for supporting dopaminergic neuron health through antioxidant-rich and anti-inflammatory foods, the gut-brain axis and its role in neuroinflammation and dopamine signaling, gentle detoxification methods targeting environmental toxins linked to Parkinson’s risk, sleep optimization for neurological repair, and specific dopamine-boosting movement and mindfulness practices. Research published in Movement Disorders (Mulak, A., & Bonaz, B., 2015, “Brain-gut-microbiota axis in Parkinson’s disease,” doi:10.1002/mds.26290) examined the bidirectional relationship between gut microbiota composition, intestinal barrier function, and Parkinson’s disease pathology — including alpha-synuclein aggregation originating in the enteric nervous system — in adult subjects. The study was conducted independently and was not affiliated with Blue Heron Health News.

Part 4 — Twelve Daily Habits to Delay Parkinson’s. Part 4 presents twelve specific daily habits organized to minimize ongoing exposure to factors scientifically linked to Parkinson’s disease progression, including environmental pollutants, Western dietary patterns, physical inactivity, chronic stress, and poor sleep quality. Each habit is framed as a manageable, daily-life adjustment rather than a clinical intervention. A systematic review published in npj Parkinson’s Disease (Bloem, B.R., et al., 2021, “Parkinson’s disease,” doi:10.1038/s41531-021-00242-2) examined modifiable lifestyle risk factors for Parkinson’s disease — including physical activity, dietary patterns, sleep quality, toxin exposure, and stress management — and their association with disease onset, progression rate, and symptom severity in adult populations across multiple longitudinal studies. The study was conducted independently and was not affiliated with Blue Heron Health News.

Supporting Science: Mitochondrial Dysfunction and Neuroinflammation in Parkinson’s. A key pillar of the program’s scientific framework is the established role of mitochondrial dysfunction and microglial neuroinflammation in dopaminergic neuron loss. Research published in Nature Genetics (Kitada, T., et al., 1998, “Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism,” doi:10.1038/ng0498-298) and subsequent work examining PINK1/Parkin mitochondrial quality control pathways established mitochondrial dysfunction as a central, targetable mechanism in Parkinson’s neurodegeneration. These studies were conducted independently and were not affiliated with Blue Heron Health News.

Market Context

The following market data is provided as independent industry context for the Parkinson’s disease management and digital health program categories in which this product operates. The figures cited are sourced from third-party market research firms and are not claims made by Blue Heron Health News regarding its own commercial performance.

The global Parkinson’s disease treatment market was valued at approximately $5.8 billion in 2024 and is projected to reach $11.4 billion by 2033, at a compound annual growth rate of 7.8 percent, according to Precedence Research (Parkinson’s Disease Treatment Market Size, Share & Trends Report 2033, Precedence Research, 2025; precedenceresearch.com). Growing consumer interest in lifestyle-based and complementary approaches to Parkinson’s symptom management has been identified as an emerging sub-segment alongside conventional pharmaceutical treatment.

The global digital health market was valued at approximately $233.0 billion in 2024 and is projected to reach $1,033.5 billion by 2034, at a compound annual growth rate of 16.0 percent, according to Precedence Research (Digital Health Market Size, Share & Trends Report 2034, Precedence Research, 2025; precedenceresearch.com). Digital lifestyle and wellness programs addressing neurological conditions including Parkinson’s disease represent one of the fastest-growing sub-segments within the broader digital health category.

The global neuroprotection market was valued at approximately $5.1 billion in 2024 and is projected to reach $9.7 billion by 2032, at a compound annual growth rate of 8.4 percent, according to Grand View Research (Neuroprotection Market Size, Share & Trends Analysis Report, 2024–2032, Grand View Research, 2024; grandviewresearch.com). Consumer adoption of dietary and lifestyle-based neuroprotection strategies, including anti-inflammatory nutrition and antioxidant supplementation, has been identified as a primary non-pharmacological demand driver in the market.

According to the Parkinson’s Foundation (Parkinson’s Foundation Statistics 2024, Parkinson’s Foundation, 2024; parkinson.org), approximately one million people in the United States are currently living with Parkinson’s disease, with approximately 90,000 new diagnoses made annually. The Parkinson’s Foundation further estimates that the total annual economic burden of Parkinson’s disease in the United States — including direct medical costs and lost productivity — exceeds $52 billion.

Availability and Purchasing

The Parkinson’s Protocol is available through Blue Heron Health News’s authorized retail portal at blueheronhealthnews.com. The program is priced at $49 (regular price $69) and is a one-time charge with no subscription, renewal, or recurring costs. All purchases include lifetime access to the digital PDF/e-book version, unlimited downloads for the purchaser and immediate family, and all future updates at no additional charge. An optional physical printed book edition is available at cost of printing only following digital purchase.

All purchases are processed through ClickBank and are subject to a 60-day no-questions-asked money-back guarantee. Product support is available through the Blue Heron Health News contact portal. Order support is available directly through ClickBank at clkbank.com.

Quality and Publishing Standards

The Parkinson’s Protocol is authored by Jodi Knapp and published by Blue Heron Health News. The program content draws on peer-reviewed research on dopaminergic neuron loss, neuroinflammation, the gut-brain axis, mitochondrial dysfunction, environmental toxin exposure, and lifestyle-based neuroprotection. The program is formatted as a clear, structured, and practical digital guide designed to be accessible to non-specialist adult readers. The program is explicitly designed to complement, not replace, conventional medical care for Parkinson’s disease.

Transactions are processed through ClickBank (Click Sales, Inc., a Delaware corporation), a registered e-commerce retailer. ClickBank’s role as retailer does not constitute an endorsement, approval, or review of the program or any claims, statements, or opinions used in its promotion. The program’s content is based on the author’s opinion and is provided on an as-is basis.

Usage Guidance

The Parkinson’s Protocol is intended for adult use as a self-directed digital health and lifestyle program. The author advises that readers continue working with their neurologist and healthcare team throughout the program, particularly individuals managing Parkinson’s disease on prescription medications or under specialist care. The program is designed to complement, not replace, professional medical care. Individual responses to lifestyle interventions may vary.

The Parkinson’s Protocol is a digital lifestyle and health education program. It is not a medical device, pharmaceutical product, or dietary supplement. The program is not intended to diagnose, treat, cure, or prevent any disease. The scientific citations included in this press release describe independent research on the mechanisms of Parkinson’s disease and lifestyle-based neuroprotection conducted under conditions unaffiliated with Blue Heron Health News. They do not constitute clinical evidence that this program produces equivalent outcomes to those described in the cited studies, and no such equivalence is claimed by the author or publisher. Readers are encouraged to consult a qualified healthcare professional — including their neurologist — before making any changes to their diet, lifestyle, or supplementation regimen. Individual results may vary.

Affiliate Disclosure: This press release may contain links to retail partner websites through which the distributor may receive compensation if a purchase is made following a referral. This disclosure is made in accordance with the Federal Trade Commission’s guidelines on endorsements and testimonials (16 CFR Part 255). The existence of this affiliate relationship does not influence the factual content of this press release.

About Blue Heron Health News

Blue Heron Health News is a digital health publishing company distributing evidence-informed wellness programs authored by health researchers and experienced practitioners. The Parkinson’s Protocol is a four-part, twelve-step digital lifestyle program authored by Jodi Knapp covering dopamine-supportive nutrition, neuroinflammation reduction, gentle detoxification, and daily habit modification for adults living with Parkinson’s disease. The program is distributed via ClickBank with a 60-day satisfaction guarantee and lifetime digital access. For more information, visit blueheronhealthnews.com.

Media Contact

Jodi Knapp

Author, The Parkinson’s Protocol

Blue Heron Health News

support@blueheronhealthnews.com

Multimedia Assets

  • Product Cover Image: blueheronhealthnews.com/health/wp-content/uploads/2024/02/Parkinsons_Protocol-smaller-228×300-1.jpg
  • Publisher Logo: blueheronhealthnews.com/health/wp-content/uploads/2015/09/logo_long.jpg
  • Money-Back Guarantee Badge: blueheronhealthnews.com/health/wp-content/uploads/2020/01/MoneyBack100-150×150-1.png

Author: Jodi Knapp, Blue Heron Health News — @BlueHeronHealth

Company: @BlueHeronHealth

Distributed By: XPR Media — @XPR_Syndicate

The post The Parkinson’s Protocol Reviews: Twelve-Step Natural Parkinson’s Lifestyle Program by Jodi Knapp Enters Commercial Market appeared first on 24 Health Times.

About The Author
pramanrt